Cognitive function and endogenous cytokine levels in children with chronic hepatitis C

Journal of Viral Hepatitis

Volumn 22, Issue 8, 2015, Pages 665-670

  Abu Faddan, N H ^a   Shehata, G A ^a   Abd Elhafeez, H A ^a   Mohamed, A O ^a   Hassan, H S ^b   Abd El Sameea, F ^b  

^a Assiut University Faculty of Medicine   (Egypt)

^b ASSIUT UNIVERSITY   (Egypt)

Author keywords

children; cognitive function; cytokines; hepatitis C

Indexed keywords

ALPHA INTERFERON; INTERLEUKIN 6; TUMOR NECROSIS FACTOR ALPHA; IL6 PROTEIN, HUMAN; TUMOR NECROSIS FACTOR;

ABSTRACT VISUAL REASONING; ADOLESCENT; ADULT; ARTICLE; BLOOD LEVEL; CHILD; CHILD HEALTH CARE; CLINICAL ARTICLE; COGNITION; COMPREHENSION; CONTROLLED STUDY; CYTOKINE BLOOD LEVEL; DEMOGRAPHY; FEMALE; HEPATITIS C; HUMAN; INTELLIGENCE QUOTIENT; LINGUISTICS; MALE; PRIORITY JOURNAL; SHORT TERM MEMORY; STANFORD-BINET INTELLIGENCE SCALE; THINKING; VIRUS LOAD; BLOOD; CASE CONTROL STUDY; CHRONIC HEPATITIS C; COGNITION DISORDERS; COMPLICATION; PATHOLOGY; PRESCHOOL CHILD;

ADOLESCENT; CASE-CONTROL STUDIES; CHILD; CHILD, PRESCHOOL; COGNITION; COGNITION DISORDERS; FEMALE; HEPATITIS C, CHRONIC; HUMANS; INTERFERON-ALPHA; INTERLEUKIN-6; MALE; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84934804536     PISSN: 13520504     EISSN: 13652893     Source Type: Journal    
DOI: 10.1111/jvh.12373     Document Type: Article

References (38)

1. Lavanchy D,. The global burden of hepatitis C. Liver Int 2009; 29 (Suppl. 1): 74-81.
2. Mohd Hanafiah K, Groeger J, Flaxman AD, Wiersma ST,. Global epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalence. Hepatology 2013; 57: 1333-1342.
3. Kamal SM, Nasser IA,. Hepatitis C genotype 4: what we know and what we don't yet know. Hepatology 2008; 47: 1371-1383.
4. El-Karaksy H, Anwar GH, El-Raziky MS, et al,. Anti-HCV prevalence among diabetic and nondiabetic Egyptian children. Curr Diabetes Rev 2010; 6: 388-392.
5. Barakat SH, El-Bashir N,. Hepatitis C virus infection among healthy Egyptian children: prevalence and risk factors. J Viral Hepat 2011; 18: 779.
6. Hilsabeck RC, Perry W, Hassanein TI,. Neuropsychological impairment in patients with chronic hepatitis C. Hepatology 2002; 35: 440-446.
7. Hilsabeck RC, Hassanein TI, Carlson MD, Ziegler EA, Perry W,. Cognitive functioning and psychiatric symptomatology in patients with chronic hepatitis C. J Int Neuropsychol Soc 2003; 9: 847-854.
8. Fontana RJ, Bieliauskas LA, Back-Madruga C, et al,. Cognitive function in hepatitis C patients with advanced fibrosis enrolled in the HALT-C trial. J Hepatol 2005; 43: 614-622.
9. Perry W, Hilsabeck RC, Hassanein TI,. Cognitive dysfunction in chronic hepatitis C: a review. Dig Dis Sci 2008; 53: 307-321.
10. Huckans M, Seelye A, Parcel T, et al,. The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder. JINS 2009; 15: 69-82.
11. McAfoose J, Baune BT,. Evidence for a cytokine model of cognitive function. Neurosci Biobehav Rev, 2009; 33: 355-366.
12. Anisman H, Poulter MO, Gandhi R, Merali Z, Hayley SL,. Interferon-α effects are exaggerated when administered on a psychosocial stressor backdrop: cytokine, corticosterone, and brain monoamine variations. J Neuroimmunol 2007; 186: 45-53.
13. Magaki S, Meuller C, Dickson C, Kirsch W,. Increased production of inflammatory cytokines in mild cognitive impairment. Exp Gerontol 2007; 42: 233-240.
14. Marsland AL, Petersen KL, Sathanoori R, et al,. Interleukin-6 covaries inversely with cognitive performance among middle-aged community volunteers. Psychosom Med 2006; 68: 895-903.
15. Chen J, Buchanan JB, Sparkman NL, Godbout JP, Freund GG, Johnson RW,. Neuroinflammation and disruption in working memory in aged mice after acute stimulation of the peripheral innate immune system. Brain Behav Immun 2008; 22: 301-311.
16. Robin CH, Gregory MA, Amy LW, et al,. Cognitive efficiency is associated with endogenous cytokine levels in patients with chronic hepatitis C. J Neuroimmunol 2010; 221: 53-61.
17. Rodrigue JR, Balistreri W, Haber B, et al,. Impact of hepatitis C virus infection on children and their caregivers: quality of life, cognitive, and emotional outcomes. J Pediatr Gastroenterol Nutr 2009; 48 (3): 341-347.
18. Taylor PC,. AssayMax mouse tumor necrosis factor alpha (TNF-alpha) ELISA. Mol Biotechnol 2001; 19 (2): 153-168.
19. Melika LK,. The Stanford-Binet Intelligence Scale, Arabic Examiner's Handbook, 4th edn. Cairo, Egypt: Dar El-Maref Publishing, 1998.
20. Delany EA, Hopkins TF,. The Stanford-Binet Intelligence Scale: Examiner's Handbook, 4th edn. Chicago: Riverside Publishing Co, 1986.
21. Shehata G, Eltayeb A,. Cognitive function and event-related potentials in children with type 1 diabetes mellitus. J Child Neurol 2010; 25: 469-474.
22. Shehata GA, Elsayh KI, Rafet NH, Mohamed AO, Rageh TA,. Study of beta-thalassemia biomarkers and their relationship to cognition among children. J Child Neurol 2010; 25: 1473-1479.
23. EL-Tallawy HN, Farghaly WM, Shehata GA, Metwally NA, Rageh TA, Abo-Elfetoh N,. Epidemiology of cerebral palsy in El-Kharga District-New Valley (Egypt). Brain Dev 2011; 33: 406-411.
24. Ferenci P, Lockwood A, Mullen K, Tarter R, Weissenborn K, Blei AT,. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: Final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002; 35: 716-721.
25. Krause J, Schuler A, Ennen JC, et al,. Cerebral function in hepatitis C patients with normal liver function. J Hepatol 2001; 34: 156.
26. Forton DM, Thomas HC, Murphy CA, et al,. Hepatitis C and cognitive impairment in a cohort of patients with mild liver disease. Hepatology 2002; 35: 433-439.
27. Pattullo V, McAndrews MP, Damyanovich A, Heathcote AE,. Influence of hepatitis C virus on neurocognitive function in patients free from other risk factors: validation from therapeutic outcomes. Liver Int 2011; 1478 (3223): 1028-1038.
28. Migita K, Abiru S, Maeda Y, et al,. Serum levels of interleukin-6 and its soluble receptors in patients with hepatitis C virus infection. Hum Immunol 2006; 67: 27-32.
29. Chen TY, Hsieh YS, Wu TT, et al,. Impact of serum levels and gene polymorphism of cytokines on chronic hepatitis C infection. Transl Res J Lab Clin Med 2007; 150: 116-121.
30. Lee S, Macquillan GC, Keane NM, et al,. Immunological markers predicting outcome in patients with hepatitis C treated with interferon-alpha and ribavirin. Immunol Cell Biol 2002; 80: 391-397.
31. Castellano-Higuera A, Gonzalez-Reimers E, Aleman-Valls MR, et al,. Cytokines and lipid peroxidation in alcoholics with chronic hepatitis C virus infection. Alcohol 2008; 43: 137-142.
32. Hilsabeck RC, Hassanein TI, Ziegler EA, Carlson MD, Perry W,. Effect of interferon-alpha on cognitive functioning in patients with chronic hepatitis C. J Int Neuropsychol Soc 2005; 11: 16-22.
33. Kraus MR, Schafer A, Wissmann S, Reimer P, Scheurlen M,. Neurocognitive changes in patients with hepatitis C receiving interferon alfa-2b and ribavirin. Clin Pharmacol Ther 2005; 77: 90-100.
34. Majer M, Welberg LAM, Capuron L, Pagnoni G, Raison CL, Miller AH,. IFN-alpha-induced motor slowing is associated with increased depression and fatigue in patients with chronic hepatitis C. Brain Behav Immun 2008; 22: 870-880.
35. Pawelczyk T, Pawelczyk A, Strzelecki D, Rabe-Jablonska J,. Pegylated interferon alpha and ribavirin therapy may induce working memory disturbances in chronic hepatitis C patients. Gen Hosp Psychiatry 2008; 30: 501-508.
36. Wrona D,. Neural-immune interactions: an integrative view of the bidirectional relationship between the brain and immune system. J Neuroimmunol 2006; 172: 38-58.
37. Forton DM, Taylor-Robinson SD, Thomas HC,. Reduced quality of life in hepatitis C-is it all in the head? J Hepatol 2002; 36: 435-438.
38. Blumenfeld H,. Neuroanatomy Through Clinical Cases. Sunderland, MA: Sinauer Associates, Inc., 2002.